<DOC>
	<DOCNO>NCT00167544</DOCNO>
	<brief_summary>The purpose study determine whether treatment preterm infant high-risk lung brain injury low dose hydrocortisone result improve pulmonary neurologic outcome .</brief_summary>
	<brief_title>Randomized Trial Hydrocortisone Very Preterm High-Risk Infants</brief_title>
	<detailed_description>Hypothesis : Among extremely low birth weight infant ( ELBW ; BW ≤ 1000 g ) high risk bronchopulmonary dysplasia ( BPD ) neurologic impairment , infant randomize seven day hydrocortisone demonstrate increase total cerebral tissue volume compare infant randomize placebo . Specific Aims : 1 ) To perform pilot blind randomize control trial 7-day regimen low dose hydrocortisone ELBW infant high risk BPD neurosensory impairment assess effect cerebral tissue volume . 2 ) Evaluate report 2 year neurodevelopmental outcome . Background Significance : Bronchopulmonary dysplasia disease arrest lung development lung inflammation . It primarily see ELBW infant . Neurological delay , include cerebral palsy mental retardation , affect 40 % -50 % survive ELBW infant . BPD important risk factor neurological delay . Postnatal administration corticosteroid ventilate preterm neonate result reduce risk develop BPD . Postnatal corticosteroid however show harmful effect brain lead increase rate cerebral palsy learn problem . This effect primarily see dexamethasone high dos give first week life . Beyond first week life , insufficient information effect steroids brain . Steroids dexamethasone , much low dos show improve short term lung function minimal short-term side effect . A review study steroid trial BPD show give high risk group infant ( &gt; 50 % risk BPD ) steroid protect brain reduce rate cerebral palsy . The American Canadian Pediatric society respect researcher comment urgent need trial corticosteroid low dos start first week life evaluate short long-term pulmonary neurological benefit risk . Research Design Methods : 1 . Inclusion &amp; Exclusion Criteria : See . 2 . Procedures : Consented eligible patient randomly assign receive hydrocortisone taper schedule 7 day placebo ( comparison group ) . Study drug give every 12 hour IV study pharmacist aware assignment . The patient 's anatomic brain MRI ( routinely do ELBW infant 38 week post-menstrual age ) process mask study investigator derive total regional brain volume . Administration indomethacin dexamethasone enrol infant closely monitor regulate throughout trial period . Indomethacin use study period contraindicate . Dexamethasone ( steroid ) use restrict ELBW infant high ventilator setting ( RIS &gt; 10 ) 28 day life . All procedure per routine care . Blinded developmental follow-up two year , already currently perform ELBW infant MHCH , analyze report study infant .</detailed_description>
	<mesh_term>Bronchopulmonary Dysplasia</mesh_term>
	<mesh_term>Premature Birth</mesh_term>
	<mesh_term>Encephalomalacia</mesh_term>
	<mesh_term>Hydrocortisone 17-butyrate 21-propionate</mesh_term>
	<mesh_term>Cortisol succinate</mesh_term>
	<mesh_term>Hydrocortisone acetate</mesh_term>
	<mesh_term>Hydrocortisone</mesh_term>
	<criteria>Patient Memorial Hermann Children 's Hospital ( MHCH ) neonatal intensive care unit birth weight ≤ 1000 gram . Ventilatordependent 10 21 day age . Respiratory index score ( RIS : mean airway pressure x fraction inspire oxygen ) ≥ 2.0 increase stable previous 24 hour RIS ≥ 3.0 improvement note past 24 hour . Prior postnatal steroid treatment . Evidence sepsis necrotizing enterocolitis . Known major congenital anomaly cardiopulmonary central nervous system . Infants treat indomethacin likely require treatment next 7 day judge treat physician . Inability unwillingness parent legal guardian/representative give write informed consent . Gestational age &lt; 23 week .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>3 Weeks</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>Bronchopulmonary Dysplasia</keyword>
	<keyword>Encephalomalacia</keyword>
	<keyword>Brain injury</keyword>
	<keyword>Neurosensory impairment</keyword>
	<keyword>Corticosteroids</keyword>
	<keyword>Anti-Inflammatory Agents</keyword>
	<keyword>Extremely Low Birth Weight ( ELBW ) infant</keyword>
	<keyword>Premature Birth</keyword>
	<keyword>Magnetic Resonance Imaging</keyword>
</DOC>